| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-06 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.3 | 4e-05 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.003 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.006 |